Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

A recent study highlights the alarming increase in death risk associated with respiratory syncytial virus (RSV) among adults.

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...